These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

898 related articles for article (PubMed ID: 16231316)

  • 21. Chromosomal instability in BRAF mutant, microsatellite stable colorectal cancers.
    Bond CE; Umapathy A; Buttenshaw RL; Wockner L; Leggett BA; Whitehall VL
    PLoS One; 2012; 7(10):e47483. PubMed ID: 23110075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of MTHFR polymorphisms and folate levels in different phenotypes of sporadic colorectal cancers.
    Chang SC; Lin PC; Lin JK; Yang SH; Wang HS; Li AF
    Int J Colorectal Dis; 2007 May; 22(5):483-9. PubMed ID: 16941173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LOH and copy neutral LOH (cnLOH) act as alternative mechanism in sporadic colorectal cancers with chromosomal and microsatellite instability.
    Melcher R; Hartmann E; Zopf W; Herterich S; Wilke P; Müller L; Rosler E; Kudlich T; Al-Taie O; Rosenwald A; Katzenberger T; Scholtka B; Seibold S; Rogoll D; Scheppach W; Scheurlen M; Lührs H
    Carcinogenesis; 2011 Apr; 32(4):636-42. PubMed ID: 21297112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microsatellite instability in poorly differentiated adenocarcinomas of the colon and rectum: relationship to clinicopathological features.
    Kazama Y; Watanabe T; Kanazawa T; Tanaka J; Tanaka T; Nagawa H
    J Clin Pathol; 2007 Jun; 60(6):701-4. PubMed ID: 17557871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of BRAF and KRAS mutation status in stage II and III microsatellite instable colon cancers.
    de Cuba EM; Snaebjornsson P; Heideman DA; van Grieken NC; Bosch LJ; Fijneman RJ; Belt E; Bril H; Stockmann HB; Hooijberg E; Punt CJ; Koopman M; Nagtegaal ID; Coupé VH; Carvalho B; Meijer GA
    Int J Cancer; 2016 Mar; 138(5):1139-45. PubMed ID: 26376292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study.
    Ahnen DJ; Feigl P; Quan G; Fenoglio-Preiser C; Lovato LC; Bunn PA; Stemmerman G; Wells JD; Macdonald JS; Meyskens FL
    Cancer Res; 1998 Mar; 58(6):1149-58. PubMed ID: 9515799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic classification of colorectal cancer based on chromosomal loss and microsatellite instability predicts survival.
    Choi SW; Lee KJ; Bae YA; Min KO; Kwon MS; Kim KM; Rhyu MG
    Clin Cancer Res; 2002 Jul; 8(7):2311-22. PubMed ID: 12114436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination of microsatellite instability and BRAF mutation status for subtyping colorectal cancer.
    Seppälä TT; Böhm JP; Friman M; Lahtinen L; Väyrynen VM; Liipo TK; Ristimäki AP; Kairaluoma MV; Kellokumpu IH; Kuopio TH; Mecklin JP
    Br J Cancer; 2015 Jun; 112(12):1966-75. PubMed ID: 25973534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Near-diploid and near-triploid human sporadic colorectal adenocarcinomas differ for KRAS2 and TP53 mutational status.
    Giaretti W; Venesio T; Sciutto A; Prevosto C; Geido E; Risio M
    Genes Chromosomes Cancer; 2003 Jun; 37(2):207-13. PubMed ID: 12696070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of heterozygosity: an independent prognostic factor of colorectal cancer.
    Chang SC; Lin JK; Lin TC; Liang WY
    World J Gastroenterol; 2005 Feb; 11(6):778-84. PubMed ID: 15682467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microsatellite instability in colorectal cancer is associated with local lymphocyte infiltration and low frequency of distant metastases.
    Buckowitz A; Knaebel HP; Benner A; Bläker H; Gebert J; Kienle P; von Knebel Doeberitz M; Kloor M
    Br J Cancer; 2005 May; 92(9):1746-53. PubMed ID: 15856045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aberrant DNA methylation profiles of inherited and sporadic colorectal cancer.
    Sahnane N; Magnoli F; Bernasconi B; Tibiletti MG; Romualdi C; Pedroni M; Ponz de Leon M; Magnani G; Reggiani-Bonetti L; Bertario L; Signoroni S; Capella C; Sessa F; Furlan D;
    Clin Epigenetics; 2015; 7():131. PubMed ID: 26697123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined Microsatellite Instability and Elevated Microsatellite Alterations at Selected Tetranucleotide Repeats (EMAST) Might Be a More Promising Immune Biomarker in Colorectal Cancer.
    Chen MH; Chang SC; Lin PC; Yang SH; Lin CC; Lan YT; Lin HH; Lin CH; Lai JI; Liang WY; Lu ML; Yang MH; Chao Y
    Oncologist; 2019 Dec; 24(12):1534-1542. PubMed ID: 31292272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microsatellite and chromosomal stable colorectal cancers demonstrate poor immunogenicity and early disease recurrence.
    Banerjea A; Hands RE; Powar MP; Bustin SA; Dorudi S
    Colorectal Dis; 2009 Jul; 11(6):601-8. PubMed ID: 18637931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proliferation, apoptosis, and survival in high-level microsatellite instability sporadic colorectal cancer.
    Michael-Robinson JM; Reid LE; Purdie DM; Biemer-Hüttmann AE; Walsh MD; Pandeya N; Simms LA; Young JP; Leggett BA; Jass JR; Radford-Smith GL
    Clin Cancer Res; 2001 Aug; 7(8):2347-56. PubMed ID: 11489812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced likelihood of metastases in patients with microsatellite-unstable colorectal cancer.
    Malesci A; Laghi L; Bianchi P; Delconte G; Randolph A; Torri V; Carnaghi C; Doci R; Rosati R; Montorsi M; Roncalli M; Gennari L; Santoro A
    Clin Cancer Res; 2007 Jul; 13(13):3831-9. PubMed ID: 17606714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of CDX2/CK20 expression is associated with poorly differentiated carcinoma, the CpG island methylator phenotype, and adverse prognosis in microsatellite-unstable colorectal cancer.
    Kim JH; Rhee YY; Bae JM; Cho NY; Kang GH
    Am J Surg Pathol; 2013 Oct; 37(10):1532-41. PubMed ID: 24025523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of clinicopathologic characteristics and genetic alterations between microsatellite instability-positive and microsatellite instability-negative sporadic colorectal carcinomas in patients younger than 40 years old.
    Suh JH; Lim SD; Kim JC; Hong SH; Kang GH
    Dis Colon Rectum; 2002 Feb; 45(2):219-28. PubMed ID: 11852336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sporadic colorectal carcinomas with low-level microsatellite instability in Korea: do they form a distinct subgroup with distinguished clinicopathological features?
    Kim YH; Min BH; Choi HK; Kim SJ; Kim KM; Kim JY; Chang DK; Son HJ; Rhee PL; Kim JJ; Rhee JC; Chun HK
    J Surg Oncol; 2009 May; 99(6):351-5. PubMed ID: 19204939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determination of TP53 mutation is more relevant than microsatellite instability status for the prediction of disease-free survival in adjuvant-treated stage III colon cancer patients.
    Westra JL; Schaapveld M; Hollema H; de Boer JP; Kraak MM; de Jong D; ter Elst A; Mulder NH; Buys CH; Hofstra RM; Plukker JT
    J Clin Oncol; 2005 Aug; 23(24):5635-43. PubMed ID: 16110022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.